Delivery Order SPE2DB24D3013-SPE2DB25FFNNB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $3,977.47. This contract represents a firm fixed-price delivery order under a competitive, non-set-aside procurement and is scheduled for completion by July 25, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office and serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $18,945.55. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 28, 2025. This...
- This is a $29,225.65 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MYRBETRIQ ER 50 MG TABLET 90S. The contract has an ultimate completion date of July 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a...
- The Defense Logistics Agency awarded a $25,044.82 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate headquarters...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,416.29 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MYRBETRIQ ER 25 MG TABLET 90S, a prescription medication. This delivery order was placed under an Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued up to $999,999,999 through December 2025, for a wide range of medical commodities to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units) under a firm fixed-price contract valued at $8,276.16. The award was made on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a routine pharmaceutical procurement...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for MYRBETRIQ ER 50 MG TABLET 90S. The $26,178.63 firm fixed-price contract has an ultimate completion date of April 13, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $21,193.42 contract is for the supply of MYRBETRIQ ER 25 MG TABLET 90S, a medication, with a performance period through April 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military and other...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,841.66 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of MYRBETRIQ ER 25 MG TABLET 30S, a pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is a part of a larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,617.24 to AmerisourceBergen Drug Corp for Myrbetriq ER 50 mg tablets (90-count supply) on July 24, 2025, with completion scheduled for July 25, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFNNBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of MYRBETRIQ ER 50 mg tablets (90-count units) valued at $3,217.23. This firm fixed-price contract, which was competitively awarded without set-aside designation, is scheduled for ultimate completion on July 22, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value pharmaceutical transaction executed through AmerisourceBergen's existing contract vehicle with the Defense Logistics Agency. This award is a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a comprehensive portfolio of medications, vaccines, and medical supplies to support military and veteran healthcare systems. The company's federal procurement track record demonstrates extensive experience fulfilling diverse pharmaceutical requirements across multiple therapeutic domains through competitively awarded contracts with firm fixed pricing structures, positioning it as a critical vendor for federal medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 7/21/25 |